Vanguard Group Portfolio holdings
AUM
$6.18T
1-Year Return
25.19%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Quarter Return
+24.86%
1 Year Return
+25.19%
3 Year Return
+103.99%
5 Year Return
+190.29%
10 Year Return
+458.75%
AUM
$2.82T
AUM Growth
+$473B
(+20%)
Cap. Flow
-$19.9B
Cap. Flow
% of AUM
-0.71%
Top 10 Holdings %
Top 10 Hldgs %
19.88%
Holding
4,167
New
87
Increased
1,559
Reduced
2,133
Closed
91
Top Buys
| 1 |
T-Mobile US
TMUS
|
$2.24B |
| 2 |
Otis Worldwide
OTIS
|
$2.22B |
| 3 |
AbbVie
ABBV
|
$2.14B |
| 4 |
Carrier Global
CARR
|
$2.06B |
| 5 |
Blackrock
BLK
|
$2.02B |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$4.45B |
| 2 |
RTN
Raytheon Company
RTN
|
$3.15B |
| 3 |
Apple
AAPL
|
$2.82B |
| 4 |
IAC Inc
IAC
|
$2.31B |
| 5 |
Microsoft
MSFT
|
$1.66B |
Sector Composition
| 1 | Technology | 22.87% |
| 2 | Healthcare | 14.01% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.9% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
10x Genomics
TXG
$1.74B
| $353M | 0.01% |
3,957,771
+2,873,055
| +265% | +$257M |
|
927
American States Water
AWR
$2.88B
| $353M | 0.01% |
4,491,474
+23,480
| +0.5% | +$1.85M |
|
928
Graphic Packaging
GPK
$6.38B
| $353M | 0.01% |
25,200,901
-1,639,816
| -6% | -$22.9M |
|
929
Vanguard ESG US Stock ETF
ESGV
$11.2B
| $352M | 0.01% |
6,250,623
+1,049,901
| +20% | +$59.2M |
|
930
Kohl's
KSS
$1.86B
| $352M | 0.01% |
16,940,819
-1,831,256
| -10% | -$38M |
|
931
First Solar
FSLR
$22B
| $352M | 0.01% |
7,107,387
-94,990
| -1% | -$4.7M |
|
932
Toll Brothers
TOL
$14.2B
| $351M | 0.01% |
10,761,712
-1,441,333
| -12% | -$47M |
|
933
Halozyme
HALO
$8.76B
| $350M | 0.01% |
13,047,599
-850,615
| -6% | -$22.8M |
|
|
AJRD
934
DELISTED
Aerojet Rocketdyne Holdings, Inc.
AJRD
| $349M | 0.01% |
8,808,378
+260,533
| +3% | +$10.3M |
|
|
GAP
935
The Gap, Inc.
GAP
$8.83B
| $349M | 0.01% |
27,662,778
-1,714,699
| -6% | -$21.6M |
|
|
GBT
936
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $348M | 0.01% |
5,519,586
-8,609
| -0.2% | -$543K |
|
937
NeoGenomics
NEO
$1.03B
| $348M | 0.01% |
11,240,602
+462,957
| +4% | +$14.3M |
|
938
Murphy USA
MUSA
$7.47B
| $348M | 0.01% |
3,087,701
-21,740
| -0.7% | -$2.45M |
|
939
Natera
NTRA
$23.1B
| $346M | 0.01% |
6,935,167
+185,551
| +3% | +$9.25M |
|
940
Regal Rexnord
RRX
$9.66B
| $345M | 0.01% |
3,955,210
-256,550
| -6% | -$22.4M |
|
941
Hexcel
HXL
$5.16B
| $345M | 0.01% |
7,621,934
-4,850
| -0.1% | -$219K |
|
942
Kinsale Capital Group
KNSL
$10.6B
| $345M | 0.01% |
2,219,669
+420,112
| +23% | +$65.2M |
|
|
BCPC
943
Balchem Corporation
BCPC
$5.23B
| $344M | 0.01% |
3,629,719
-110,486
| -3% | -$10.5M |
|
944
Novanta
NOVT
$4.18B
| $344M | 0.01% |
3,222,266
-10,544
| -0.3% | -$1.13M |
|
945
United Bankshares
UBSI
$5.42B
| $344M | 0.01% |
12,433,537
+2,350,710
| +23% | +$65M |
|
|
RETA
946
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $344M | 0.01% |
2,203,551
-36,177
| -2% | -$5.64M |
|
947
Qualys
QLYS
$4.87B
| $342M | 0.01% |
3,287,477
-310,102
| -9% | -$32.3M |
|
948
Thomson Reuters
TRI
$78.7B
| $341M | 0.01% |
4,840,407
-873,956
| -15% | -$61.6M |
|
949
Community Bank
CBU
$3.17B
| $341M | 0.01% |
5,972,113
-170,005
| -3% | -$9.69M |
|
|
QVCGA
950
QVC Group, Inc. Series A Common Stock
QVCGA
$73.3M
| $340M | 0.01% |
736,488
-20,443
| -3% | -$9.43M |
|